EVs steadily growing; fuel cell EVs align with the future
As environmental awareness rises, consumer demand for electric vehicles (EVs) is gradually increasing, providing opportunities for the development of the…
Taiwan’s 2025 AI outlook: data center transformation and sovereign AI
The rise of generative AI has elevated Taiwan’s global standing, as it plays a crucial role in providing the hardware…
In-depth analysis: AI drives automotive innovation at CES 2025
At the Consumer Electronics Show (CES) 2025, DIGITIMES analyst Mark Yu provided insights into smart mobility breakthroughs and future developments,…
Recall of La Fiesta Brand Bread Crumbs (Unseasoned and Seasoned) for Undeclared Sesame
La Fiesta Food Products, LLC, La Mirada, CA is recalling 8 oz packages of La Fiesta brand Unseasoned Bread Crumbs…
Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories
To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support…
TS Food Packaging is Recalling its “Rural King” and “Wabash Valley Farms” Bacon Seasoning Due to the Presence of an Undeclared Soy Ingredient
TS Food Packaging is recalling its “Rural King” and “Wabash Valley Farms” Bacon Seasoning due to the presence of an…
Division of Applied Regulatory Science
The Division of Applied Regulatory Science is located within FDA’s Office of Clinical Pharmacology and tackles emerging regulatory questions and…
Mexico creates nearshoring incentives in push for regional integration
The new package is a pillar of President Claudia Sheinbaum’s long-term plan to bolster the country’s role in North America’s…
Provepharm Inc. Issues Voluntary Nationwide Recall of One Lot of Phenylephrine Hydrochloride Injection, USP, 10 mg/ mL (Pharmacy Bulk Package) Due to Presence of Particulate Matter
Collegeville, Pennsylvania, Provepharm Inc. is voluntarily recalling lot number 24020027; Expiry Date December 2025 of Phenylephrine hydrochloride Injection, USP, 10…
Safety announcement: FDA highlights importance of DPD deficiency discussions with patients prior to capecitabine or 5FU treatment
The FDA is providing this communication to increase awareness of recent updates to the product labeling of capecitabine and fluorouracil…